PAMS
Pictet Asset Management (Switzerland) Portfolio holdings
AUM
$84.3B
1-Year Return
26.45%
This Quarter Return
+7.81%
1 Year Return
+26.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$84.3B
AUM Growth
+$4.57B
(+5.7%)
Cap. Flow
-$79.4M
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,062
New
93
Increased
623
Reduced
800
Closed
105
Top Buys
| 1 |
Amazon
AMZN
|
$216M |
| 2 |
Xylem
XYL
|
$183M |
| 3 |
Agilent Technologies
A
|
$163M |
| 4 |
NVIDIA
NVDA
|
$148M |
| 5 |
Ecolab
ECL
|
$142M |
Top Sells
| 1 |
Salesforce
CRM
|
$269M |
| 2 |
Comcast
CMCSA
|
$181M |
| 3 |
Equinix
EQIX
|
$178M |
| 4 |
Wabtec
WAB
|
$166M |
| 5 |
Tesla
TSLA
|
$163M |
Sector Composition
| 1 | Technology | 29.57% |
| 2 | Healthcare | 16.47% |
| 3 | Industrials | 15.66% |
| 4 | Utilities | 8.94% |
| 5 | Consumer Discretionary | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Jazz Pharmaceuticals
JAZZ
$7.86B
| $46.3M | 0.05% |
373,392
+135,445
| +57% | +$16.8M |
|
302
Coherent
COHR
$15.2B
| $46.2M | 0.05% |
906,461
-2,278,974
| -72% | -$116M |
|
303
Goldman Sachs
GS
$223B
| $46M | 0.05% |
142,609
+1,446
| +1% | +$466K |
|
304
Zurn Elkay Water Solutions
ZWS
$7.71B
| $45.8M | 0.05% |
1,703,635
+75,018
| +5% | +$2.02M |
|
|
BPMC
305
DELISTED
Blueprint Medicines
BPMC
| $45.7M | 0.05% |
723,766
+150,122
| +26% | +$9.49M |
|
306
MoonLake Immunotherapeutics
MLTX
$3.77B
| $45.6M | 0.05% |
+894,005
| New | +$45.6M |
|
307
W.W. Grainger
GWW
$47.5B
| $45.5M | 0.05% |
57,740
+3,382
| +6% | +$2.67M |
|
308
Ametek
AME
$43.3B
| $45.3M | 0.05% |
280,016
-16,612
| -6% | -$2.69M |
|
309
Boeing
BA
$174B
| $45.3M | 0.05% |
214,339
-8,410
| -4% | -$1.78M |
|
310
Interparfums
IPAR
$3.63B
| $45M | 0.05% |
332,624
+5,052
| +2% | +$683K |
|
311
UDR
UDR
$13B
| $44.7M | 0.05% |
1,040,706
-78,779
| -7% | -$3.38M |
|
312
Stryker
SYK
$150B
| $44.4M | 0.05% |
145,394
+3,170
| +2% | +$967K |
|
313
Travelers Companies
TRV
$62B
| $44.2M | 0.05% |
254,486
-5,305
| -2% | -$921K |
|
314
American Tower
AMT
$92.9B
| $43.9M | 0.05% |
226,244
+2,746
| +1% | +$533K |
|
315
BridgeBio Pharma
BBIO
$10.2B
| $43.6M | 0.05% |
2,532,716
+1,090,284
| +76% | +$18.8M |
|
316
Charles Schwab
SCHW
$167B
| $42.6M | 0.05% |
752,370
+61,312
| +9% | +$3.48M |
|
317
Intellia Therapeutics
NTLA
$1.29B
| $42.6M | 0.05% |
1,044,579
+104,083
| +11% | +$4.24M |
|
318
Cognizant
CTSH
$35.1B
| $42.4M | 0.05% |
649,531
+29,079
| +5% | +$1.9M |
|
319
Cigna
CI
$81.5B
| $42.2M | 0.05% |
150,450
+6
| +0% | +$1.68K |
|
320
McKesson
MCK
$85.5B
| $41.9M | 0.05% |
97,965
+988
| +1% | +$422K |
|
321
Manulife Financial
MFC
$52.1B
| $41.6M | 0.05% |
2,198,134
+200,601
| +10% | +$3.8M |
|
322
Global Payments
GPN
$21.3B
| $41.2M | 0.05% |
418,201
-537,391
| -56% | -$52.9M |
|
323
Perrigo
PRGO
$3.12B
| $41.1M | 0.05% |
1,211,820
+51,703
| +4% | +$1.76M |
|
324
Medpace
MEDP
$13.7B
| $40.9M | 0.05% |
170,468
+60,178
| +55% | +$14.5M |
|
325
Gulfport Energy Corp
GPOR
$3.08B
| $40.7M | 0.05% |
387,100
-256
| -0.1% | -$26.9K |
|